Please use this identifier to cite or link to this item:
Title: A study of multiple drug resistance mechanisms improved against Bortezomib on multiple myeloma cell lines in vitro
Authors: Uyuklu, Tolga
Ural, A. Uğur
Sarper, Metal
Avcu, Ferit
Baran, Yusuf
Elçi, Pınar
Akar, Nejat
Issue Date: 2007
Publisher: American Society of Hematology
Abstract: The most important problem in the treatment of Multiple Myeloma (MM) is the multi drug resistance (MDR) observed before and after the treatment. For this reason in MM cases an early resistance to treatment can be developed or the disease can relapsed in early period. Yet, there has been no improved drug resistance against proteazom inhibitor Bortezomib (Bor), which is used alone or with other chemotherapeutic agents in resistant or relapsed MM cases
Description: 49th Annual Meeting of the American-Society-of-Hematology
ISSN: 0006-4971
Appears in Collections:Molecular Biology and Genetics / Moleküler Biyoloji ve Genetik
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File SizeFormat 
1-s2.0-S0006497118404351-main.pdf62.24 kBAdobe PDFView/Open
Show full item record

CORE Recommender

Page view(s)

checked on Mar 20, 2023


checked on Mar 20, 2023

Google ScholarTM



Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.